Guangdong Hybribio Biotech Co., Ltd. (300639.SZ) announced that its wholly-owned subsidiary, Chaozhou Kaipu Bio-Chemistry Co., Ltd. (referred to as "Kaipu Chemistry"), has recently obtained the "Medical Device Registration Certificate (In Vitro Diagnostic Reagent)" issued by the National Medical Products Administration of China.
The certified product is the Chikungunya Virus/Dengue Virus Nucleic Acid Detection Kit (Fluorescent PCR Method), intended for the in vitro qualitative detection of chikungunya virus and dengue virus nucleic acids in human serum or plasma samples.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.